Evidence map›Paper›PMID 34022043›Full record

ReviewRheumatology (Oxford, England)2021

Infections in immunosuppressed travellers with autoimmune inflammatory diseases-a narrative review and advice for clinical practice.

Victoria Allen, Nicky Longley

Abstract readReview
In one paragraph

Review in Rheumatology (Oxford, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Victoria AllenDepartment of Academic Rheumatology, King's College London.
Nicky LongleyHospital for Tropical Diseases.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The management of autoimmune, inflammatory diseases has been revolutionized by biologic therapies. A beneficial consequence of better disease control is that more patients are well enough to travel the world. There is now a class of traveller, the significantly immunosuppressed person with autoimmune disease, with specific risks and requirements. This review introduces the concept of the pre-travel risk assessment and discusses the major vaccine-preventable and non-vaccine-preventable travel-associated infections. The challenges and controversies around vaccination and immunosuppression are reviewed with advice for clinical practice.

Indexed as

Communicable Disease ControlRisk AssessmentTravel-Related IllnessAutoimmune DiseasesHumansImmunocompromised HostVaccine-Preventable Diseasesautoimmune diseaseimmunosuppressed travellersimmunosuppressiontargeted therapiestravel medicinetravel-related infectionstravel risk assessmenttravel vaccinesvaccine responsesvisiting friends and relatives

Identifiers

PMID34022043
PMCPMC8409992

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.